MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease.
J Bras Nefrol
; 41(3): 412-422, 2019.
Article
em En, Pt
| MEDLINE
| ID: mdl-30742700
ABSTRACT
Diabetic kidney disease (DKD) is a chronic complication of diabetes mellitus associated with significant morbidity and mortality regarded as a global health issue. MicroRNAs - small RNA molecules responsible for the post-transcriptional regulation of gene expression by degradation of messenger RNA or translational repression of protein synthesis - rank among the factors linked to the development and progression of DKD. This study aimed to offer a narrative review on investigations around the use of microRNAs in the diagnosis, monitoring, and treatment of DKD. Various microRNAs are involved in the pathogenesis of DKD, while others have a role in nephroprotection and thus serve as promising therapeutic targets for DKD. Serum and urine microRNAs levels have also been considered in the early diagnosis and monitoring of individuals with DKD, since increases in albuminuria, decreases in the glomerular filtration rate, and progression of DKD have been linked to changes in the levels of some microRNAs.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
MicroRNAs
/
Nefropatias Diabéticas
Idioma:
En
/
Pt
Ano de publicação:
2019
Tipo de documento:
Article